NASDAQ: CING
Cingulate Inc Stock Forecast, Predictions & Price Target

Analyst price target for CING

Based on 3 analysts offering 12 month price targets for Cingulate Inc

Min Forecast
$11.00+157.01%
Avg Forecast
$30.67+616.52%
Max Forecast
$61.00+1,325.23%

Should I buy or sell CING stock?

Based on 3 analysts offering ratings for Cingulate Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CING's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CING as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CING stock forecasts and price targets.

CING stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-27
lockedlocked$00.00+00.00%2025-05-19
lockedlocked$00.00+00.00%2025-03-06

1 of 1

Forecast return on equity

Is CING forecast to generate an efficient return?

Company
N/A
Industry
165.03%
Market
89.46%

Forecast return on assets

Is CING forecast to generate an efficient return on assets?

Company
N/A
Industry
43.47%

CING earnings per share forecast

What is CING's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$3.07
Avg 2 year Forecast
-$2.44
Avg 3 year Forecast
-$0.05

CING revenue forecast

What is CING's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$6.2M
Avg 2 year Forecast
$15.2M
Avg 3 year Forecast
$22.2M

CING vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CING$4.28$30.67+616.52%Strong Buy
MRKR$1.60$10.25+540.63%Strong Buy
BCAB$0.38$1.00+165.96%Buy
MEIP$2.68N/AN/A
BIVI$0.96N/AN/A

Cingulate Stock Forecast FAQ

Is Cingulate Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CING) stock is to Strong Buy CING stock.

Out of 3 analysts, 1 (33.33%) are recommending CING as a Strong Buy, 2 (66.67%) are recommending CING as a Buy, 0 (0%) are recommending CING as a Hold, 0 (0%) are recommending CING as a Sell, and 0 (0%) are recommending CING as a Strong Sell.

If you're new to stock investing, here's how to buy Cingulate stock.

What is CING's earnings growth forecast for 2025-2027?

(NASDAQ: CING) Cingulate's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.

Cingulate's earnings in 2025 is -$16,375,951.On average, 3 Wall Street analysts forecast CING's earnings for 2025 to be -$13,034,339, with the lowest CING earnings forecast at -$15,581,767, and the highest CING earnings forecast at -$10,529,368. On average, 4 Wall Street analysts forecast CING's earnings for 2026 to be -$10,338,311, with the lowest CING earnings forecast at -$14,053,310, and the highest CING earnings forecast at -$6,368,570.

In 2027, CING is forecast to generate -$212,286 in earnings, with the lowest earnings forecast at -$212,286 and the highest earnings forecast at -$212,286.

What is CING's revenue growth forecast for 2026-2028?

(NASDAQ: CING) Cingulate's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.26%.

Cingulate's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast CING's revenue for 2026 to be $26,472,021, with the lowest CING revenue forecast at $19,954,851, and the highest CING revenue forecast at $32,989,190. On average, 2 Wall Street analysts forecast CING's revenue for 2027 to be $64,365,009, with the lowest CING revenue forecast at $42,881,701, and the highest CING revenue forecast at $85,848,317.

In 2028, CING is forecast to generate $94,254,829 in revenue, with the lowest revenue forecast at $94,254,829 and the highest revenue forecast at $94,254,829.

What is CING's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CING) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 43.47%.

What is CING's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CING price target, the average CING price target is $30.67, with the highest CING stock price forecast at $61.00 and the lowest CING stock price forecast at $11.00.

On average, Wall Street analysts predict that Cingulate's share price could reach $30.67 by May 27, 2026. The average Cingulate stock price prediction forecasts a potential upside of 616.52% from the current CING share price of $4.28.

What is CING's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CING) Cingulate's current Earnings Per Share (EPS) is -$8.48. On average, analysts forecast that CING's EPS will be -$3.07 for 2025, with the lowest EPS forecast at -$3.67, and the highest EPS forecast at -$2.48. On average, analysts forecast that CING's EPS will be -$2.44 for 2026, with the lowest EPS forecast at -$3.31, and the highest EPS forecast at -$1.50. In 2027, CING's EPS is forecast to hit -$0.05 (min: -$0.05, max: -$0.05).

What is CING's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CING) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.